Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ
5
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
US Stock MarketDetailed Quotes
DSNKY Daiichi Sankyo (ADR)
- 23.000
- -1.410-5.78%
15min DelayTrading May 12 09:30 ET
42.99BMarket Cap21.46P/E (TTM)
23.000High23.000Low266Volume23.000Open24.410Pre Close6.12KTurnover0.00%Turnover Ratio21.46P/E (Static)1.87BShares42.22852wk High3.81P/B42.99BFloat Cap20.92052wk Low0.19Dividend TTM1.87BShs Float42.228Historical High0.81%Div YieldTTM0.00%Amplitude17.943Historical Low23.000Avg Price1Lot Size
About Daiichi Sankyo (ADR) Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Executive Chairman of the Board and Chief Executive Officer
- --
- Takashi Matsumoto
- Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
- --
- Hiroyuki Okuzawa
- Director, President and Chief Operating Officer
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Kazuaki Kama
- Chairman of the Board
- --
- Sawako Nohara
- Independent Director
- --
- Yo Honma
- Independent Director
- --
- Yasuhiro Komatsu
- Independent Director
- --
- Takaaki Nishii
- Independent Director
- --
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
